Aspira Women's Health

Website

Aspira Women's Health Inc.

27 Investors
Women's Health Diagnostics
AUSTIN, TX

Aspira Women's Health Inc. is a leading bio-analytical women's health company dedicated to the development of innovative diagnostic tools specifically for gynecologic diseases. With a strong focus on enhancing early detection and risk assessment, particularly for ovarian cancer, Aspira aims to address significant challenges in women's health diagnostics.

Products & Team

OvaSuite

Diagnostic Blood TestsSeed

OvaSuite is a comprehensive suite of blood tests designed to aid in the assessment of ovarian cancer risk. It includes specific tests tailored to monitor and evaluate the presence of malignancy in adnexal masses.

Value Proposition

Aspira’s products address the critical need for accurate risk assessment and early detection of ovarian cancer, enabling informed clinical management decisions and improving patient outcomes.

Pain Points

The difficulty of early-stage diagnosis for ovarian cancer and gynecologic diseases, leading to delayed treatment options and increased morbidity.

OvaWatch: Monitors adnexal masses assessed as indeterminate or benignOva1Plus: Evaluates malignancy risk prior to surgery by combining the Ova1 and Overa tests
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
AUSTIN, TX
Primary headquarters

Funding History

Total Raised:
$1.4M
E

Equity, Debt Financing Offering

Closed
March 2025
$1.4M
Raised
Progress
100%
Raised
$1.4M
Target
$1.4M
#000164117225000052